STOCKS TRADE MIXED WITH U.S. JOBS DATA FRONT OF MIND

Powell says Fed needs more evidence of falling inflation before cutting interest rates

DCTH Feb 2025 12.500 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

1.1500

0.0000

(0.00%)

As of 10:52AM EDT. Market open.

Simply Wall St.
Investors in Delcath Systems (NASDAQ:DCTH) have unfortunately lost 90% over the last five years
It is a pleasure to report that the Delcath Systems, Inc. ( NASDAQ:DCTH ) is up 75% in the last quarter. But spare a...
Business Wire
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
NEW YORK, May 28, 2024--Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.
GuruFocus.com
Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Explore Delcath Systems Inc's robust Q1 2024 performance, featuring significant revenue growth, operational expansions, and strategic insights into future profitability.